Neurology · Burlington, MA
Neurology studies in Burlington, MA
3 recruiting studies have a site in Burlington.
3 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Dianthus Therapeutics
- Location
- Burlington, MA + 29 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
- Location
- Burlington, MA + 42 other US sites
- Eligibility basics
- Ages 40–70
- RecruitingPhase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
AB Science
- Location
- Burlington, MA + 5 other US sites
- Eligibility basics
- Ages 18–81
Who these studies look for
Most require a confirmed diagnosis; memory studies often ask for a study partner who knows you well to attend some visits.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.